CL
AVNS

CSS LLC’s Avanos Medical AVNS Stock Holding History

CSS LLC’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
+12,900
New +$302K 0.01% 672

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

CSS LLC's AVNS Position: Q1 2023 in Review

CSS LLC sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 9,000 shares — an estimated $244K sold.

CSS LLC first reported a position in AVNS in Q3 2022 and held it in 2 quarters. The position peaked at $261K in Q3 2022. 286 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

  • CSS LLC reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
  • CSS LLC sold 9,000 Avanos Medical shares in Q1 2023, an estimated $244K.
  • CSS LLC first reported a position in Avanos Medical in Q3 2022 and held it in 2 quarters.
  • CSS LLC's Avanos Medical position peaked at $261K in Q3 2022.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on CSS LLC's 13F filing for Q1 2023, filed 15 May 2023.